Panel Discussion: Steering Global Commercialization Landscapes to Usher Liquid Biopsy Assays from Innovation to the Patient to Improve Global Commercial Reach
Time: 12:30 pm
day: Day Two Track B AM
Details:
• How to ensure liquid biopsy assays are being adequately regulated in the EU vs US vs Japan vs China?
• What are regulatory agencies looking for to design the assays?
• What are the challenges to bring liquid biopsy technologies to market, related to regulatory approval based on country-specific requirements?
• What are the different pathways to commercialize liquid biopsies?
